C G Missouris|P A Swift|D R Singer - JoVE Visualize

Showing results (51-60 of 94) with videos related to

Pageof 10

Sort By:

Journal of Hypertension|April 1, 1992

Is atrial natriuretic peptide-guanosine 3',5' cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension?G A Sagnella, D R Singer, N D Markandu, et al.

American Journal of Hypertension|December 1, 1990

N-terminal pro atrial natriuretic peptide in human plasmaM G Buckley, G A Sagnella, N D Markandu, et al.

Clinical Science (London, England : 1979)|April 1, 1990

Abnormal arterial flow pattern in untreated essential hypertension: possible link with the development of atherosclerosisC J Jones, D R Singer, N V Watkins, et al.

Hypertension (Dallas, Tex. : 1979)|June 1, 1991

Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazideD R Singer, N D Markandu, A L Sugden, et al.

Lancet (London, England)|November 25, 1989

Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertensionG A MacGregor, N D Markandu, G A Sagnella, et al.

Postgraduate Medical Journal|December 1, 1994

Unusual cause of orthopnoea: primary tracheal tumour mimicking left ventricular failureT F Antonios, D R Singer, F J Millard, et al.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989

Potassium channel stimulation in normal subjects and in patients with essential hypertension: an acute study with cromakalim (BRL 34915)D R Singer, N D Markandu, M A Miller, et al.

Clinical Science (London, England : 1979)|July 1, 1993

Atrial natriuretic peptide-cyclic GMP relationships in normal humans: effects of dietary sodium intakeG A Sagnella, N D Markandu, M G Buckley, et al.

Clinical Science (London, England : 1979)|October 29, 2000

Circulating C-type natriuretic peptide is increased in orthotopic cardiac transplant recipients and associated with cardiac allograft vasculopathyM G Buckley, G H Jenkins, A G Mitchell, et al.

Arzneimittel-Forschung|February 1, 1990

Studies on antifungal agents. Novel cis-5-alkyl (or alkenyl)-3-phenyl-3-(1H-azol-1-ylmethyl)-2-methyl-isoxazolidine derivativesG A Bennett, P A Swift, G B Mullen, et al.

Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:

Pageof 10

Journal of Hypertension|April 1, 1992

Is atrial natriuretic peptide-guanosine 3',5' cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension?G A Sagnella, D R Singer, N D Markandu, et al.

American Journal of Hypertension|December 1, 1990

N-terminal pro atrial natriuretic peptide in human plasmaM G Buckley, G A Sagnella, N D Markandu, et al.

Clinical Science (London, England : 1979)|April 1, 1990

Abnormal arterial flow pattern in untreated essential hypertension: possible link with the development of atherosclerosisC J Jones, D R Singer, N V Watkins, et al.

Hypertension (Dallas, Tex. : 1979)|June 1, 1991

Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazideD R Singer, N D Markandu, A L Sugden, et al.

Lancet (London, England)|November 25, 1989

Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertensionG A MacGregor, N D Markandu, G A Sagnella, et al.

Postgraduate Medical Journal|December 1, 1994

Unusual cause of orthopnoea: primary tracheal tumour mimicking left ventricular failureT F Antonios, D R Singer, F J Millard, et al.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989

Potassium channel stimulation in normal subjects and in patients with essential hypertension: an acute study with cromakalim (BRL 34915)D R Singer, N D Markandu, M A Miller, et al.

Clinical Science (London, England : 1979)|July 1, 1993

Atrial natriuretic peptide-cyclic GMP relationships in normal humans: effects of dietary sodium intakeG A Sagnella, N D Markandu, M G Buckley, et al.

Clinical Science (London, England : 1979)|October 29, 2000

Circulating C-type natriuretic peptide is increased in orthotopic cardiac transplant recipients and associated with cardiac allograft vasculopathyM G Buckley, G H Jenkins, A G Mitchell, et al.

Arzneimittel-Forschung|February 1, 1990

Studies on antifungal agents. Novel cis-5-alkyl (or alkenyl)-3-phenyl-3-(1H-azol-1-ylmethyl)-2-methyl-isoxazolidine derivativesG A Bennett, P A Swift, G B Mullen, et al.

Pageof 10